Cargando…

Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss

The muscular dystrophy X-linked mouse (mdx) is the most commonly used preclinical model for Duchenne muscular dystrophy. Although disease progression in the mouse does not perfectly model the human disease, it shares many pathological features. Early characterizations of the model reported severe pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Massopust, Ryan T., Lee, Young il, Pritchard, Anna L., Nguyen, Van-Khoa M., McCreedy, Dylan A., Thompson, Wesley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560899/
https://www.ncbi.nlm.nih.gov/pubmed/33057110
http://dx.doi.org/10.1038/s41598-020-74192-9
_version_ 1783595175592853504
author Massopust, Ryan T.
Lee, Young il
Pritchard, Anna L.
Nguyen, Van-Khoa M.
McCreedy, Dylan A.
Thompson, Wesley J.
author_facet Massopust, Ryan T.
Lee, Young il
Pritchard, Anna L.
Nguyen, Van-Khoa M.
McCreedy, Dylan A.
Thompson, Wesley J.
author_sort Massopust, Ryan T.
collection PubMed
description The muscular dystrophy X-linked mouse (mdx) is the most commonly used preclinical model for Duchenne muscular dystrophy. Although disease progression in the mouse does not perfectly model the human disease, it shares many pathological features. Early characterizations of the model reported severe pathology through early adulthood followed by disease stabilization. As a result, research in the mdx mouse has largely focused on early adulthood. The overarching goal of this study is to improve the understanding of the mdx mouse model by tracking pathological features of the disease throughout life. We performed a thorough characterization of myofiber pathology in mdx mice from 2 weeks to 2 years of age. We report that individual mdx muscle fibers undergo progressive hypertrophy that continues through the lifespan. Despite massive hypertrophy on the myofiber level, we report no hypertrophy on the muscle level. These seemingly contradictory findings are explained by previously underappreciated myofiber loss in mdx mice. We conclude that due to myofiber loss, in combination with the progressive nature of other pathological features, aged mdx muscle tissue provides reliable benchmarks for disease progression that may be valuable in testing the efficacy of therapeutics for Duchenne muscular dystrophy.
format Online
Article
Text
id pubmed-7560899
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75608992020-10-19 Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss Massopust, Ryan T. Lee, Young il Pritchard, Anna L. Nguyen, Van-Khoa M. McCreedy, Dylan A. Thompson, Wesley J. Sci Rep Article The muscular dystrophy X-linked mouse (mdx) is the most commonly used preclinical model for Duchenne muscular dystrophy. Although disease progression in the mouse does not perfectly model the human disease, it shares many pathological features. Early characterizations of the model reported severe pathology through early adulthood followed by disease stabilization. As a result, research in the mdx mouse has largely focused on early adulthood. The overarching goal of this study is to improve the understanding of the mdx mouse model by tracking pathological features of the disease throughout life. We performed a thorough characterization of myofiber pathology in mdx mice from 2 weeks to 2 years of age. We report that individual mdx muscle fibers undergo progressive hypertrophy that continues through the lifespan. Despite massive hypertrophy on the myofiber level, we report no hypertrophy on the muscle level. These seemingly contradictory findings are explained by previously underappreciated myofiber loss in mdx mice. We conclude that due to myofiber loss, in combination with the progressive nature of other pathological features, aged mdx muscle tissue provides reliable benchmarks for disease progression that may be valuable in testing the efficacy of therapeutics for Duchenne muscular dystrophy. Nature Publishing Group UK 2020-10-14 /pmc/articles/PMC7560899/ /pubmed/33057110 http://dx.doi.org/10.1038/s41598-020-74192-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Massopust, Ryan T.
Lee, Young il
Pritchard, Anna L.
Nguyen, Van-Khoa M.
McCreedy, Dylan A.
Thompson, Wesley J.
Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss
title Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss
title_full Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss
title_fullStr Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss
title_full_unstemmed Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss
title_short Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss
title_sort lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560899/
https://www.ncbi.nlm.nih.gov/pubmed/33057110
http://dx.doi.org/10.1038/s41598-020-74192-9
work_keys_str_mv AT massopustryant lifetimeanalysisofmdxskeletalmusclerevealsaprogressivepathologythatleadstomyofiberloss
AT leeyoungil lifetimeanalysisofmdxskeletalmusclerevealsaprogressivepathologythatleadstomyofiberloss
AT pritchardannal lifetimeanalysisofmdxskeletalmusclerevealsaprogressivepathologythatleadstomyofiberloss
AT nguyenvankhoam lifetimeanalysisofmdxskeletalmusclerevealsaprogressivepathologythatleadstomyofiberloss
AT mccreedydylana lifetimeanalysisofmdxskeletalmusclerevealsaprogressivepathologythatleadstomyofiberloss
AT thompsonwesleyj lifetimeanalysisofmdxskeletalmusclerevealsaprogressivepathologythatleadstomyofiberloss